Patienterne blev randomiseret til clopidogrel (300 mg initial stabiliseringsdosis efterfulgt af 75 mg/ dag, N=6. 259) eller placebo (N=6. 303), begge i kombination med ASA (75- 325 mg en gang daglig) samt anden standardbehandling.
Patients were randomised to clopidogrel (300 mg loading dose followed by 75 mg/ day, N=6,259) or placebo (N=6,303), both given in combination with ASA (75-325 mg once daily) and other standard therapies.